Literature DB >> 10764329

Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma.

F Bureau1, G Bonizzi, N Kirschvink, S Delhalle, D Desmecht, M P Merville, V Bours, P Lekeux.   

Abstract

Asthma is a chronic inflammatory disease of the airways, in which many inflammatory genes are overexpressed. Transcription factor, nuclear factor-kappaB (NF-kappaB), which is thought to control the transcriptional initiation of inflammatory genes, has been poorly investigated in asthma. In the present report, bronchial cells (BCs), recovered by bronchial brushing in healthy and heaves-affected horses (i.e., an animal model of asthma), were assessed for NF-kappaB activity. Small amounts of active NF-kappaB were present in BCs of healthy horses, whereas high levels of NF-kappaB activity was found during crisis (i.e., acute airway obstruction) in all heaves-affected horses. Three weeks after the crisis, the level of NF-kappaB activity found in BCs of heaves-affected horses was highly correlated (p < 0.01) to the degree of residual lung dysfunction. Unexpectedly, active NF- kappaB complexes found in BCs of heaves-affected horses were mainly p65 homodimers, rather than classic p65-p50 heterodimers. At last, intercellular adhesion molecule-1 (ICAM-1) expression paralleled p65 homodimers activity in these cells. These results demonstrate that the kinetics of NF-kappaB activity is strongly related to the course of the disease and confirm the relevance of NF-kappaB as a putative target in asthma therapy. Moreover, uncommon p65 homodimers could transactivate, in BCs, a subset of genes, such as ICAM-1, characteristic of chronic airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764329     DOI: 10.1164/ajrccm.161.4.9907010

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Increased Visfatin Expression Is Associated with Nuclear Factor-κB in Obese Ovalbumin-Sensitized Male Wistar Rat Tracheae.

Authors:  Mohammad Reza Aslani; Rana Keyhanmanesh; Mohammad Reza Alipour
Journal:  Med Princ Pract       Date:  2017-04-16       Impact factor: 1.927

Review 2.  Use of cell permeable NBD peptides for suppression of inflammation.

Authors:  I Strickland; S Ghosh
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

3.  Reaginic antibodies from horses with recurrent airway obstruction produce mast cell stimulation.

Authors:  G Moran; H Folch; C Henriquez; A Ortloff; M Barria
Journal:  Vet Res Commun       Date:  2012-08-12       Impact factor: 2.459

4.  Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway.

Authors:  R K Turlej; L Fiévez; C F Sandersen; S Dogné; N Kirschvink; P Lekeux; F Bureau
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

5.  Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin.

Authors:  Dae Yong Kim; Bum Soo Park; Gwan Ui Hong; Byung Jae Lee; Jung Won Park; Soo Youl Kim; Jai Youl Ro
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction.

Authors:  Gabriel Moran; Virginia A Buechner-Maxwell; Hugo Folch; Claudio Henriquez; Juan S Galecio; Barbara Perez; Cristian Carrasco; Miguel Barria
Journal:  Vet Res Commun       Date:  2011-05-19       Impact factor: 2.459

7.  Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation.

Authors:  Matthew E Poynter; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

8.  NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness.

Authors:  Matthew E Poynter; Roy Cloots; Tiest van Woerkom; Kelly J Butnor; Pamela Vacek; Douglas J Taatjes; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

9.  Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.

Authors:  F Blasi; S Damato; R Cosentini; P Tarsia; R Raccanelli; S Centanni; L Allegra
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 10.  Nuclear factor-kappaB: its role in health and disease.

Authors:  Ashok Kumar; Yasunari Takada; Aladin M Boriek; Bharat B Aggarwal
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.